Skip to Content

Humana Inc - Stock Quote HUM

Rating as of

Morningstar's Humana Inc Stock Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Despite Medicare Advantage Weakness, Humana Performs Well in Q1 and Boosts 2022 Outlook

Julie Utterback, CFA Senior Equity Analyst

Analyst Note

| Julie Utterback, CFA |

Even with weak enrollment in its Medicare Advantage (MA) stronghold, narrow-moat Humana turned in better-than-expected profits in the first quarter, and management increased its guidance for 2022. After considering these trends and tweaking our near-term assumptions a bit, we do not anticipate changing our fair value estimate. Humana shares currently trade at a mild discount to our $485 fair value estimate and continue to move closer to intrinsic value after trading in deep 4-star territory when the MA concerns initially emerged in January.

Read Full Analysis

Humana Inc's Company Profile

Business Description

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Contact
500 West Main Street
Louisville, KY, 40202
T +1 502 580-1000
Sector Healthcare
Industry Healthcare Plans
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2022
Stock Type Slow Growth
Employees 95,500

Humana Inc's Related News